FDA-Drug2026-08-19Class IIPACKAGING DEFECT
Apollo Care semaglutide injection recalled for particulate matter contamination
What this means
Apollo Care's semaglutide 12.5 mg injectable medication was found to contain small particles of nylon/polyamide and silk-like material. The contamination affects multiple lots distributed nationwide. No injuries have been reported.
- If you have one of the affected lots, do not use the vial.
- Contact your pharmacy or healthcare provider for a replacement or guidance.
- Check your vial label for lot number AC-017108, AC-017110, AC-017112, AC-017142, AC-017144, AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, or AC-017225.
The agency's original wording
Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
56,918 vials.
Manufactured in
3801 Mojave Ct Ste 101, Columbia, MO, United States
Products
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0747-2026More Apollo Care recalls
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
- FDA-Drug2026-08-19Apollo Care semaglutide injection recalled for particulate matter contamination
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.